Literature DB >> 31567293

Th2 inflammatory responses in the development of nasal polyps and chronic rhinosinusitis.

Gwanghui Ryu1, Dae Woo Kim2.   

Abstract

PURPOSE OF REVIEW: Pathogenesis of nasal polyp has been largely studied based on innate and adaptive immunity of sinonasal mucosa. So far, various factors have been identified that trigger an inflammatory response in the pathogenesis of nasal polyps. In this review, we summarized recently updated information in the understanding of mechanisms in the development of chronic rhinosinusitis with nasal polyp (CRSwNP) focusing on Th2 inflammation. RECENT
FINDINGS: Endotype of CRSwNP presented mainly Th2-skewed inflammation, and it has been associated with refractoriness and comorbidities. Staphylococcus aureus can drive Th2 inflammation by producing enterotoxins and serine protease-like protein. Moreover, S. aureus directly affected mucosal barrier function and enhanced Th2 cytokine production by fast induction of epithelial-derived innate cytokines. Epithelial-derived innate cytokines, including TSLP, IL-25, and IL-33, promote Th2 responses via the development of innate lymphoid cells. Mast cell expresses IL-5, IL-13, and periostin, and it plays a role in the pathogenesis of nasal polyps through orchestrating eosinophil infiltration. Formation of eosinophil extracellular traps and Charcot-Leyden crystals is strongly associated with disease severity and viscous mucus plug production. Therefore, it needs to be investigated mechanistically. The role of neutrophils in Th2 inflammation has been poorly understood but appears to enhance Th2 inflammation and make it more resistant to steroid therapy.
SUMMARY: There is growing evidence of the role of S. aureus in innate and adaptive immunity, which contribute to Th2 inflammation in CRSwNP. Innate immunity, including epithelial-derived cytokines, plays a crucial role in the development of CRSwNP by inducing various pathways and need to be investigated more as Th2-targeted biomarkers. Recently, the role of neutrophilic inflammation in Th2 inflammation has started to be studied but still remains unclear.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31567293     DOI: 10.1097/ACI.0000000000000588

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  14 in total

1.  The Long-Term Effects of Budesonide Nasal Irrigation in Chronic Rhinosinusitis with Asthma.

Authors:  Seon Min Jung; Jin Hye Kwak; Moo Keon Kim; Kyung Tae; Seok Hyun Cho; Jin Hyeok Jeong
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

2.  Involvement of the extracellular matrix proteins periostin and tenascin C in nasal polyp remodeling by regulating the expression of MMPs.

Authors:  Kun Du; Min Wang; Nan Zhang; Pei Yu; Ping Wang; Ying Li; Xiangdong Wang; Luo Zhang; Claus Bachert
Journal:  Clin Transl Allergy       Date:  2021-09-06       Impact factor: 5.657

3.  Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics.

Authors:  Mark C Liu; Bradley Chipps; Xavier Munoz; Gilles Devouassoux; Miguel Bergna; Steven G Smith; Robert G Price; Dmitry V Galkin; Jay Azmi; Dalal Mouneimne; Frank C Albers; Kenneth R Chapman
Journal:  Respir Res       Date:  2021-05-10

Review 4.  Monoclonal Antibodies and Airway Diseases.

Authors:  Annina Lyly; Anu Laulajainen-Hongisto; Philippe Gevaert; Paula Kauppi; Sanna Toppila-Salmi
Journal:  Int J Mol Sci       Date:  2020-12-13       Impact factor: 5.923

Review 5.  Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region.

Authors:  Mona Al-Ahmad; Saad Alsaleh; Heba Al-Reefy; Janan Al Abduwani; Iman Nasr; Rashid Al Abri; Ahmed Mohd Haider Alamadi; Ayman Ali Fraihat; Abdulmohsen Alterki; Mohamed Abuzakouk; Osama Marglani; Hussain Al Rand
Journal:  J Asthma Allergy       Date:  2022-01-04

6.  Characterization of Cytokines and Proliferation Marker Ki67 in Chronic Rhinosinusitis with Nasal Polyps: A Pilot Study.

Authors:  Rudolfs Janis Viksne; Gunta Sumeraga; Mara Pilmane
Journal:  Medicina (Kaunas)       Date:  2021-06-11       Impact factor: 2.430

7.  Correlation of Bromodomain Protein BRD4 Expression With Epithelial-Mesenchymal Transition and Disease Severity in Chronic Rhinosinusitis With Nasal Polyps.

Authors:  Xuanchen Zhou; Zhaoyang Cui; Yiqing Liu; Zhiyong Yue; Fengyang Xie; Ling Ding; Shuai Xu; Jie Han; Hong Zhang
Journal:  Front Med (Lausanne)       Date:  2020-08-14

Review 8.  Airway Epithelial Dynamics in Allergy and Related Chronic Inflammatory Airway Diseases.

Authors:  Anu Laulajainen-Hongisto; Sanna Katriina Toppila-Salmi; Annika Luukkainen; Robert Kern
Journal:  Front Cell Dev Biol       Date:  2020-03-27

Review 9.  Staphylococcus aureus Infection and Persistence in Chronic Rhinosinusitis: Focus on Leukocidin ED.

Authors:  Dimitri Poddighe; Luca Vangelista
Journal:  Toxins (Basel)       Date:  2020-10-28       Impact factor: 4.546

10.  Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma.

Authors:  Nicola Lombardo; Corrado Pelaia; Marco Ciriolo; Marcello Della Corte; Giovanna Piazzetta; Nadia Lobello; Pasquale Viola; Girolamo Pelaia
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.